Your search returned 17 studies. (Get alerts for new studies):
- Phase I/II Trial of VELCADE Plus Zevalin in Patients With Relapsed or Refractory Follicular Lymphoma
Conditions: Lymphoma
4 Locations available
- Vaccination for the Treatment of Previously Untreated or Relapsed Follicular Lymphoma
Conditions: Follicular Lymphoma
1 Location available
- GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
Conditions: Lymphoma
1 Location available
- Oral Clofarabine for Relapsed/Refractory Indolent B-cell NHL and Mantle Cell Lymphoma
Conditions: Follicular Lymphoma - Marginal Zone Lymphoma - Mantle Cell Lymphoma - Small Lymphocytic Lymphoma - Lymphoplasmacytic Lymphoma - Low Grade B-cell Lymphoma, Not Otherwise Specified
2 Locations available
- Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom
Conditions: Lymphoma
2 Locations available
- Lenalidomide and Rituximab in Treating Patients With Follicular or Small Lymphocytic Non-Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatm
Conditions: Lymphoma
1 Location available
- Evaluate Rituximab in Obtaining PCR Negative Leukapheresis Product in Patients With Relapsed Follicular Lymphoma
Conditions: Non-Hodgkins Lymphoma
2 Locations available
- Effectiveness of a Blood Stem Cell Transplant That Uses Low Dose Chemotherapy in People With Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN #0701
Conditions: Lymphoma, Non-Hodgkin
34 Locations available
- A Phase 1-2 Study of CAT-8015 in Adult Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia (CLL) - Diffuse Large B-Cell Lymphoma (DLBCL) - Non-Hodgkin's Lymphoma (NHL) - Follicular Lymphoma (FL) - Mantle Cell Lymphoma (MCL)
1 Location available
- Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma
Conditions: Follicular Lymphoma - Marginal Zone Lymphoma
1 Location available
- Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
Conditions: Lymphoma, Non-Hodgkin
11 Locations available
- Single Agent Ofatumumab Vs. Single Agent Rituximab in Follicular Lymphoma Relapsed After Rituximab-Containing Therapy
Conditions: Lymphoma, Follicular
14 Locations available
- Study of HCD122 (Lucatumumab) and Bendamustine Combination Therapy in CD40+ Relapsed Follicular Lymphoma
Conditions: Follicular Lymphoma
3 Locations available
- Imexon for Relapsed Follicular and Aggressive Lymphomas
Conditions: Follicular Lymphoma - Diffuse Large B Cell Lymphoma - Mantle Cell Lymphoma - Burkitt's Lymphoma
1 Location available
- Ofatumumab and Bortezomib in Subjects With Relapsed CD20+ NHL
Conditions: Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Grade 1 Follicular Lymphoma - Recurrent Grade 2 Follicular Lymphoma - Recurrent Grade 3 Follicular Lymphoma - Recurrent Mantle Cell Lymphoma
1 Location available
- MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab & Vincristine
Conditions: Diffuse Large B-Cell Lymphoma - Transformed Follicular Lymphoma - Mantle Cell Lymphoma - Burkitt's Lymphoma
1 Location available
- Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma
Conditions: Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Nodal Marginal Zone B-cell Lymphoma - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Grade 1 Follicular Lymphoma - Recurrent Grade 2 Follicular Lymphoma - Recurrent G
1 Location available
|